Dow Today: Johnson & Johnson (JNJ) Lower

The Dow Jones Industrial Average (^DJI) is trading down 136 points (-1.1%) at 12,754 as of Friday, Feb 10, 2012, 1:39 p.m. ET. During this time, 413.2 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 818.6 million. The NYSE advances/declines ratio sits at 632 issues advancing vs. 2,323 declining with 103 unchanged.

Holding back the Dow today is Johnson & Johnson (NYSE:JNJ), which is lagging the broader Dow index with a 40-cent decline (-0.6%) bringing the stock to $64.49. This single loss is lowering the Dow Jones Industrial Average by 3.03 points or roughly accounting for 2.2% of the Dow's overall loss. Volume for Johnson & Johnson currently sits at 6.8 million shares traded vs. an average daily trading volume of 10.7 million shares.

Johnson & Johnson has a market cap of $177.51 billion and is part of the health care sector and drugs industry. Shares are down 1.1% year to date as of Thursday's close. The stock's dividend yield sits at 3.5%.

Johnson & Johnson engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The company has a P/E ratio of 13, below the average drugs industry P/E ratio of 15.9 and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Johnson & Johnson as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

For more information on Dow Jones Industrial Average click any of the following:

TheStreet Premium Services

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
Dow Jones S&P 500 NASDAQ 10-Year Note
12,251.77 1,310.33 2,787.18 14.74
Oil *
98.91
DOWN
141.68
DOWN
2.99
DOWN
40.16
DOWN
1.07
10 Yr
1.47%
SPDR Gold
151.62
-1.14%
-0.23%
-1.42%
-6.77%
Data delayed 20 minutes

Latest Trade Alerts

See all

Articles From